Orion Oyj B (ORNBV.HE) — Technical state
As of 2026-10-30 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 62 out of 100 (momentum 91 · quality 84 · valuation 30), as of 2026-11-01.
- Signal: Uptrend stack intact — Trades +19.3% vs the 50-day and +34.4% vs the 200-day average, 0.5% below the 52-week high and +79.4% off the 52-week low. Computed from daily closes. (as of 2026-10-30)
- Trend: Orion Oyj B trades 19.3% above its 50-day and 34.4% above its 200-day moving average. (as of 2026-10-30)
Orion Oyj develops, makes and sells human and veterinary medicines together with active pharmaceutical ingredients, headquartered in Espoo, Finland. It sells prescription drugs for prostate cancer, Parkinson's disease, asthma and pain, plus veterinary treatments and self-care products such as supplements and skincare, marketed across Nordic, European and international markets.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ORNBV.HE overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades +19.3% vs the 50-day and +34.4% vs the 200-day average, 0.5% below the 52-week high and +79.4% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+13.1%
- vs 50-day+19.3%
- vs 200-day+34.4%
- 52-week band0.5% off the high · +79.4% off the low
- Streak3 consecutive up sessions
- 50-day crossprice crossed up through the 50-day 14 sessions ago
- Stochastic%K 97.3 · %D 90.9 · bull cross
Continue: the ORNBV.HE chart & overview · quality & forensics · the signal board
FAQ · from the current data · as of 2026-10-30
Quick answers
What is the current Closelooknet signal on ORNBV.HE?
Uptrend stack intact — Trades +19.3% vs the 50-day and +34.4% vs the 200-day average, 0.5% below the 52-week high and +79.4% off the 52-week low. Computed from daily closes. As of 2026-10-30; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is ORNBV.HE above its 50-day and 200-day moving averages?
As of 2026-10-30, Orion Oyj B trades +19.3% above its 50-day and +34.4% above its 200-day average, with the 20-day +13.1% away.
How far is ORNBV.HE from its 52-week high?
0.5% below the 52-week high and 79.4% above the 52-week low, as of 2026-10-30.
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNAV.HE Orion Oyj Aindustry
- SAN.PA Sanofi SAindustry
- AMGN Amgen Incindustry
- NVO Novo Nordisk A/Sindustry
- AZN.L AstraZeneca PLCindustry
- GILD Gilead Sciences Incindustry
- BIIB Biogen Incindustry
- ABBV AbbVie Incindustry
- PFE Pfizer Incindustry
- SNY Sanofi ADRindustry
- JNJ Johnson & Johnsonindustry
- MRK Merck & Company Incindustry
- OGN Organon & Coindustry
- BMY Bristol-Myers Squibb Companyindustry
- 002422.SHE Sichuan Kelun Pharmaceutical Co Ltdindustry
- AZN AstraZeneca PLCindustry
- CMHC.SW COSMO N NVindustry
- REG1V.HE Revenio Group Corporationsector
- TTALO.HE Terveystalo Oysector